General Information of Drug Off-Target (DOT) (ID: OT8DXIAT)

DOT Name UPF0461 protein C5orf24 (C5ORF24)
Gene Name C5ORF24
UniProt ID
CE024_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF17724
Sequence
MMHPVASSNPAFCGPGKPSCLNEDAMRAADQFDIYSSQQSKYSHTVNHKPMVCQRQDPLN
ETHLQTTSGRSIEIKDELKKKKNLNRSGKRGRPSGTTKSAGYRTSTGRPLGTTKAAGFKT
SPGRPLGTTKAAGYKVSPGRPPGSIKALSRLADLGYGCGTAAFPYPMMHGRAVHGVEETS
SEVKPPNE

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
8 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the expression of UPF0461 protein C5orf24 (C5ORF24). [1]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide increases the expression of UPF0461 protein C5orf24 (C5ORF24). [2]
Vorinostat DMWMPD4 Approved Vorinostat decreases the expression of UPF0461 protein C5orf24 (C5ORF24). [3]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of UPF0461 protein C5orf24 (C5ORF24). [4]
SNDX-275 DMH7W9X Phase 3 SNDX-275 decreases the expression of UPF0461 protein C5orf24 (C5ORF24). [5]
Geldanamycin DMS7TC5 Discontinued in Phase 2 Geldanamycin increases the expression of UPF0461 protein C5orf24 (C5ORF24). [8]
Torcetrapib DMDHYM7 Discontinued in Phase 2 Torcetrapib increases the expression of UPF0461 protein C5orf24 (C5ORF24). [9]
Trichostatin A DM9C8NX Investigative Trichostatin A decreases the expression of UPF0461 protein C5orf24 (C5ORF24). [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of UPF0461 protein C5orf24 (C5ORF24). [6]
TAK-243 DM4GKV2 Phase 1 TAK-243 decreases the sumoylation of UPF0461 protein C5orf24 (C5ORF24). [7]
------------------------------------------------------------------------------------

References

1 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
2 Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802.
3 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
4 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
5 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
6 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
7 Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.
8 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
9 Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach. BMC Syst Biol. 2012 Dec 10;6:152.